This HTML5 document contains 43 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

PrefixIRI
wdthttp://www.wikidata.org/prop/direct/
schemahttp://schema.org/
skoshttp://www.w3.org/2004/02/skos/core#
rdfshttp://www.w3.org/2000/01/rdf-schema#
wikibasehttp://wikiba.se/ontology#
phttp://www.wikidata.org/prop/
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
xsdhhttp://www.w3.org/2001/XMLSchema#
wdshttp://www.wikidata.org/entity/statement/
wdhttp://www.wikidata.org/entity/

Statements

Subject Item
wd:Q62025694
rdf:type
wikibase:Item
schema:description
клінічне випробування ensayo clínico klinisch onderzoek clinical trial ensayu clínicu
rdfs:label
Non-Interventional Study in Patients With Relapsed or Refractory Mantle Cell Lymphoma (R/R MCL) to Investigate the Association of Lenalidomide With Tumor Flare Reaction and High Tumor Burden
skos:prefLabel
Non-Interventional Study in Patients With Relapsed or Refractory Mantle Cell Lymphoma (R/R MCL) to Investigate the Association of Lenalidomide With Tumor Flare Reaction and High Tumor Burden
schema:name
Non-Interventional Study in Patients With Relapsed or Refractory Mantle Cell Lymphoma (R/R MCL) to Investigate the Association of Lenalidomide With Tumor Flare Reaction and High Tumor Burden
p:P1476
wds:Q62025694-A627710B-275A-4F56-A30A-6C16F08D3A0E
wdt:P1476
A Non-interventional, Post-authorization Safety Study of Patients With Relapsed or Refractory Mantle Cell Lymphoma to Further Investigate and Characterize the Association of Lenalidomide With Tumor Flare Reaction and High Tumor Burden
p:P582
wds:Q62025694-15C53AFD-4437-469E-B329-69F2B6441F40
wdt:P582
2026-12-31T00:00:00Z
p:P31
wds:Q62025694-135D2F81-0C80-422E-BA23-DAD4DD08CF18
wdt:P31
wd:Q30612
p:P580
wds:Q62025694-BA9C277B-257F-4EF2-9284-77CC97825277
wdt:P580
2018-09-30T00:00:00Z
p:P921
wds:Q62025694-B68C52E0-4764-44BF-A9E1-03D85B0E4E3D
wdt:P921
wd:Q425681
p:P6153
wds:Q62025694-0F368CD2-D7DB-4044-9C1B-34DB4534D5E1 wds:Q62025694-E2388054-AC53-493F-908B-18476E87ED75 wds:Q62025694-6AD4B981-0D71-478D-8D47-2D0F678DCCC2
wdt:P6153
wd:Q5902531 wd:Q30279623 wd:Q3297837
p:P1813
wds:Q62025694-05C07582-143A-4BE2-8196-7F843D95FE57
wdt:P1813
PASS MCL-005
p:P4844
wds:Q62025694-9740975B-3256-4DB4-962E-018E6F360754
wdt:P4844
wd:Q425681
p:P2899
wds:Q62025694-A845A8B4-9F57-414F-B108-D7D329C1BD2B
wdt:P2899
18
p:P1050
wds:Q62025694-981D2704-DFBF-42A0-81FD-DC5F849D9DB4
p:P859
wds:Q62025694-104213CC-385E-48D6-9E0F-835FB7F0048E
wdt:P1050
wd:Q208414
wdt:P859
wd:Q842947
p:P1132
wds:Q62025694-D9B879ED-153C-4AAD-A6AB-563D2F33A310
wdt:P1132
560
p:P8363
wds:Q62025694-D63C7140-D763-43CC-860F-D224D36A69BC
wdt:P8363
wd:Q818574
p:P3098
wds:Q62025694-2CDE1BE0-A6AA-4DD6-9B50-B0C14E80188E
wdt:P3098
NCT03647124
p:P8005
wds:Q62025694-F47780D7-1476-436A-8962-8CD2C584CE31
wdt:P8005
wd:Q76649708